E
AEON Biopharma, Inc. AEON
$0.75 -$0.07-8.16% AMEX
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
EPS (TTM)

09/30/2025 06/30/2025 03/31/2025 12/31/2024 09/30/2024
Total Cash And Short-Term Investments 1,003.72% 145.18% 570.47% -99.75% -96.68%
Total Receivables -- -- -- -- --
Inventory -- -- -- -- --
Prepaid Expenses -19.03% 215.94% 99.47% 48.21% 149.86%
Finance Division Loans and Leases Current -- -- -- -- --
Total Finance Division Other Current Assets -- -- -- -- --
Other Current Assets -- -- -- -- --
Total Current Assets 212.61% 155.34% 393.23% -74.45% -85.98%

Total Current Assets 212.61% 155.34% 393.23% -74.45% -85.98%
Net Property, Plant & Equipment -19.39% -18.68% 186.93% 156.40% 136.23%
Long-term Investments -- -- -- -- --
Goodwill -- -- -- -- --
Total Other Intangibles -- -- -- -- --
Finance Div Loans & Leases LT -- -- -- -- --
Total Finance Div Other LT Assets -- -- -- -- --
Total Other Assets 0.00% 0.00% 0.00% 0.00% 0.00%
Total Assets 118.13% 103.38% 355.11% -54.10% -77.27%

Total Accounts Payable -45.46% 28.94% -62.64% 74.44% 15.38%
Total Accrued Expenses -8.58% -31.45% -3.58% -13.48% -39.52%
Short-term Debt -- -- -- -- --
Current Portion of Long-Term Debt/Capital Leases -- -- -- -- --
Finance Division Debt Current 92.97% 80.60% -3.90% -56.47% -56.76%
Total Finance Division Other Current Liabilities -- -- -- -- --
Total Other Current Liabilities -- -- -- -- --
Total Current Liabilities -23.29% -12.47% -45.85% 8.43% -24.34%

Total Current Liabilities -23.29% -12.47% -45.85% 8.43% -24.34%
Long-Term Debt 12.40% 14.16% 161.84% -- --
Short-term Debt -- -- -- -- --
Capital Leases -20.51% -19.18% -- -- 2,215.38%
Finance Division Debt Non Current -- -- -- -- --
Total Finance Division Other Non Current Liabilities -- -- -- -- --
Total Other Liabilities -73.65% -74.81% -98.85% -96.78% -93.18%
Total Liabilities -20.75% -18.31% -87.53% -80.17% -75.28%

Common Stock & APIC 3.04% 3.44% 4.56% 5.71% 5.77%
Retained Earnings 0.00% -0.38% 28.59% 8.87% 3.06%
Treasury Stock & Other -- -- -- -- --
Total Common Equity 38.07% 43.28% 94.29% 81.33% 75.01%

Preferred Stock Redeemable -- -- -- -- --
Preferred Stock Non Redeemable -- -- -- -- --
Preferred Stock Convertible -- -- -- -- --
Preferred Stock, Others -- -- -- -- --
Total Preferred Equity -- -- -- -- --

Total Common Equity 38.07% 43.28% 94.29% 81.33% 75.01%
Total Preferred Equity -- -- -- -- --
Total Minority Interest -- -- -- -- --
Total Equity 38.07% 43.28% 94.29% 81.33% 75.01%